mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.02 |
mRNA |
XMD13-2 |
GDSC1000 |
pan-cancer |
AAC |
-0.073 |
0.02 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.02 |
mRNA |
Tipifarnib |
GDSC1000 |
pan-cancer |
AAC |
0.083 |
0.02 |
mRNA |
GSK690693 |
GDSC1000 |
pan-cancer |
AAC |
-0.075 |
0.02 |
mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.02 |
mRNA |
SR8278 |
CTRPv2 |
pan-cancer |
AAC |
0.29 |
0.02 |
mRNA |
HG-6-64-1 |
GDSC1000 |
pan-cancer |
AAC |
0.079 |
0.02 |
mRNA |
Merck60 |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.02 |
mRNA |
JNK Inhibitor VIII |
GDSC1000 |
pan-cancer |
AAC |
0.078 |
0.02 |